Opsoclonus myoclonus syndrome, abbreviated OMS and also called opsoclonus-myoclonus-ataxia or OMA, is a rare neurological disorder whose cause is unknown. It appears to result from an autoimmune process that involves the nervous system. The condition is extremely uncommon, affecting as few as one person in ten million each year. It is seen in about two to three percent of children who have neuroblastoma, and it has also been reported together with celiac disease and with diseases marked by neurologic and autonomic dysfunction. Because the cause is not established, the autoimmune explanation is best read as the leading working account rather than a settled fact.
Facts
Classification
ICD-10 ChapterVI: Diseases of the Nervous System 1 Communicable or Non-communicable Causative Agent
Causative Agent (category) First Described Sources
1. Opsoclonus myoclonus syndrome (Wikipedia)
Lead, first sentence
appears to be the result of an autoimmune process involving the nervous system
Lead, first sentence [body-system]
is a rare neurological disorder of unknown cause
lead sentence 1
Opsoclonus myoclonus syndrome (OMS), also known as opsoclonus-myoclonus-ataxia (OMA), is a rare neurological disorder of unknown cause which appears to be the result of an autoimmune process involving the nervous system.
Lead: disease category
Opsoclonus myoclonus syndrome (OMS), also known as opsoclonus-myoclonus-ataxia (OMA), is a rare neurological disorder of unknown cause which appears to be the result of an autoimmune process involving the nervous system.
Article text
OMS was first described by Marcel Kinsbourne in 1962.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.